Bicara Therapeutics Announces Pricing of Upsized Initial Public Offering
September 12, 2024 21:15 ET
|
Bicara Therapeutics Inc.
BOSTON, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients...